{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:15:43Z","timestamp":1792289743750,"version":"4.4.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T00:00:00Z","timestamp":1413504000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109834","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T21:41:01Z","timestamp":1413841261000},"page":"e109834","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of T-Type Calcium Channel Blockers on Renal Function and Aldosterone in Patients with Hypertension: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Xue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1046\/j.1523-1755.1999.00434.x","article-title":"Class differences in the effects of calcium channel blockers in the rat remnant kidney model","volume":"55","author":"KA Griffin","year":"1999","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.5301\/JN.2011.6383","article-title":"One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease","volume":"24","author":"Y Tomino","year":"2011","journal-title":"J Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1254\/jphs.FMJ05002X5","article-title":"Pathophysiological significance of T-type Ca<sup>2+<\/sup> channels: T-type Ca<sup>2+<\/sup> channels and drug development","volume":"99","author":"H Tanaka","year":"2005","journal-title":"Pharmacol Sci"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Marin R, Gorostidi M, Fernandez-Vega F, Alvarez-Navascues R (2005) Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl 99: 52\u201356.","DOI":"10.1111\/j.1523-1755.2005.09910.x"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1291\/hypres.28.611","article-title":"Effects of vasopeptidase inhibition on renal function and tubuloglomerular feedback in spontaneously hypertensive rats","volume":"28","author":"T Wang","year":"2005","journal-title":"Hypertens Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1254\/jphs.FMJ05002X6","article-title":"Pathophysiological significance of T-type Ca<sup>2+<\/sup> channels: role of T-type Ca<sup>2+<\/sup> channels in renal microcirculation","volume":"99","author":"K Hayashi","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ki.1981.68","article-title":"Angiotensin receptors in glomeruli differ from those in renal arterioles","volume":"19","author":"WJ Caldicott","year":"1981","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"BM Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"P Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjhyper.2004.06.029","article-title":"Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease","volume":"18","author":"A Sato","year":"2005","journal-title":"Am J Hypertens"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e57854","DOI":"10.1371\/journal.pone.0057854","article-title":"The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials","volume":"8","author":"GJ Chen","year":"2013","journal-title":"PLoS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijcard.2011.10.133","article-title":"A Crossover Comparison of Urinary Albumin Excretion as a New Surrogate Marker for Cardiovascular Disease among 4 Types of Calcium Channel Blockers","volume":"166","author":"T Konoshita","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000338132","article-title":"Long-Term Effects of Calcium Antagonists on Augmentation Index in Hypertensive Patients with Chronic Kidney Disease: A Randomized Controlled Study","volume":"35","author":"T Takenaka","year":"2012","journal-title":"Am J Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/clc.20885","article-title":"Calcium Channel Blocker Inhibition of Age and Rage Axis Limits Renal Injury in Nondiabetic Patients with Stage I or Ii Chronic Kidney Disease","volume":"34","author":"T Nakamura","year":"2011","journal-title":"Clin Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/hr.2010.221","article-title":"Benidipine Reduces Albuminuria and Plasma Aldosterone in Mild-to-Moderate Stage Chronic Kidney Disease with Albuminuria","volume":"34","author":"M Abe","year":"2011","journal-title":"Hypertens Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/hr.2011.67","article-title":"Additive Antioxidative Effects of Azelnidipine on Angiotensin Receptor Blocker Olmesartan Treatment for Type 2 Diabetic Patients with Albuminuria","volume":"34","author":"M Abe","year":"2011","journal-title":"Hypertens Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1536\/ihj.51.188","article-title":"Effects of Efonidipine, an L- and T-Type Calcium Channel Blocker, on the Renin-Angiotensin-Aldosterone System in Chronic Hemodialysis Patients","volume":"51","author":"N Nakano","year":"2010","journal-title":"Int Heart J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MAJ.0b013e3181c643df","article-title":"Comparative Effects of Benidipine and Amlodipine on Proteinuria, Urinary 8-Ohdg, Urinary L-Fabp, and Inflammatory and Atherosclerosis Markers in Early-Stage Chronic Kidney Disease","volume":"339","author":"T Nakamura","year":"2010","journal-title":"Am J Med Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/hr.2009.78","article-title":"Long-Term Effect of Efonidipine Therapy on Plasma Aldosterone and Left Ventricular Mass Index in Patients with Essential Hypertension","volume":"32","author":"T Tsutamoto","year":"2009","journal-title":"Hypertens Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.5551\/jat.1628","article-title":"Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy","volume":"16","author":"H Sasaki","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/hr.2009.11","article-title":"Comparison of the Antiproteinuric Effects of the Calcium Channel Blockers Benidipine and Amlodipine Administered in Combination with Angiotensin Receptor Blockers to Hypertensive Patients with Stage 3\u20135 Chronic Kidney Disease","volume":"32","author":"M Abe","year":"2009","journal-title":"Hypertens Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1586\/14779072.6.10.1347","article-title":"Add-on Manidipine Versus Amlodipine in Diabetic Patients with Hypertension and Microalbuminuria: The Amandha Study","volume":"6","author":"FJ Martinez-Martin","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.30.691","article-title":"Comparison of the Effects of Efonidipine and Amlodipine on Aldosterone in Patients with Hypertension","volume":"30","author":"T Tanaka","year":"2007","journal-title":"Hypertens Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MAJ.0b013e318065c254","article-title":"Azelnidipine Reduces Urinary Protein Excretion and Urinary Liver-Type Fatty Acid Binding Protein in Patients with Hypertensive Chronic Kidney Disease","volume":"333","author":"T Nakamura","year":"2007","journal-title":"Am J Med Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1291\/hypres.30.621","article-title":"Efonidipine Reduces Proteinuria and Plasma Aldosterone in Patients with Chronic Glomerulonephritis","volume":"30","author":"T Ishimitsu","year":"2007","journal-title":"Hypertens Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1291\/hypres.28.889","article-title":"Beneficial Effect of T-Type Calcium Channel Blockers on Endothelial Function in Patients with Essential Hypertension","volume":"28","author":"T Oshima","year":"2005","journal-title":"Hypertens Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2169\/internalmedicine.43.561","article-title":"Effects of the Long-Acting Calcium Channel Blockers, Amlodipine, Manidipine and Cilnidipine on Steroid Hormones and Insulin Resistance in Hypertensive Obese Patients","volume":"43","author":"H Ueshiba","year":"2004","journal-title":"Intern Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1081\/JDI-120024284","article-title":"Effects of Manidipine and Nifedipine on Blood Pressure and Renal Function in Patients with Chronic Renal Failure: A Multicenter Randomized Controlled Trial","volume":"25","author":"G Bellinghieri","year":"2003","journal-title":"Ren Fail"},{"key":"ref29","first-page":"401","article-title":"Observed the efficacy of benidipine combined with benazepril treatment of hypertension nephropathy","volume":"7","author":"RQ Han","year":"2013","journal-title":"Clinical drug of the world"},{"key":"ref30","unstructured":"Gong ML, Gao YX, Zhang J (2012) Benidipine combined with valsartan on renal function in patients with essential hypertension. Chinese Medicine 14: 95\u201396+99. (in Chinese)."},{"key":"ref31","first-page":"201","article-title":"Effect of valsartan and benidipine on renal function in patients with essential hypertension with proteinuria","volume":"27","author":"JS Gan","year":"2012","journal-title":"China Pharmaceutical Guide"},{"key":"ref32","first-page":"54","article-title":"Benidipine and perindopril in elderly hypertensive patients with proteinuria affect renal function","volume":"11","author":"B Dong","year":"2011","journal-title":"Journal of China Modern Medicine"},{"key":"ref33","first-page":"647","article-title":"A Comparative Study of the Renoprotective Effects of Benidipine and Valsartan in Primary Hypertensive Patients with Proteinuria","volume":"59","author":"T Peng","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"ref34","first-page":"261","article-title":"Efficacy and Tolerability of Manidipine in the Treatment of Hypertension in Patients with Non-Diabetic Chronic Kidney Disease without Glomerular Disease. Prospective, Randomized, Double-Blind Study of Parallel Groups in Comparison with Enalapril","volume":"17","author":"L Del Vecchio","year":"2004","journal-title":"J Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0895-7061(02)03147-3","article-title":"Effect of Efonidipine and Ace Inhibitors on Proteinuria in Human Hypertension with Renal Impairment","volume":"16","author":"K Hayashi","year":"2003","journal-title":"Am J Hypertens"},{"key":"ref36","first-page":"4011","article-title":"Advances in anti-hypertensive drugs and clinical evaluation","volume":"42","author":"ZG Fan","year":"2010","journal-title":"Chinese pharmacy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF02584016","article-title":"The effect of two different calcium antagonists on the glomerular haemodynamics in dogs","volume":"415","author":"J Heller","year":"1990","journal-title":"Eur J Physiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.HYP.5.4.482","article-title":"Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs","volume":"5","author":"JR Dietz","year":"1983","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00005344-198303000-00015","article-title":"Effects of the calcium antagonist nicardipine on renal function and renin release in dogs","volume":"5","author":"Y Abe","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref40","first-page":"E410","article-title":"Effects of verapamil on renin and aldosterone in the dog and rat","volume":"245","author":"M Roy","year":"1983","journal-title":"Am J Physiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca<sup>2+<\/sup> Channel Subtypes and Pharmacology in the Kidney","volume":"100","author":"K Hayashi","year":"2007","journal-title":"Circ Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"E Perez-Reyes","year":"2003","journal-title":"Physiol Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(98)00204-0","article-title":"Inhibition of myocardial L- and T-type Ca<sup>2+<\/sup> currents by efonidipine: possible mechanism for chronotropic effect","volume":"349","author":"H Masumiya","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(98)01018-X","article-title":"Effect of nilvadipine on the voltagedependent Ca<sup>2+<\/sup> channels in rat hippocampal CA1 pyramidal neurons","volume":"813","author":"H Ishibashi","year":"1998","journal-title":"Brain Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.RES.75.1.144","article-title":"Selective inhibition of T-type Ca<sup>2+<\/sup> channels by Ro 40\u20135967","volume":"75","author":"SK Mishra","year":"1994","journal-title":"Circ Res"},{"key":"ref46","first-page":"54","article-title":"Voltage-dependent blockade of diverse types of voltage-gated Ca<sup>2+<\/sup> channels expressed in Xenopus oocytes by the Ca<sup>2+<\/sup> channel antagonist mibefradil (Ro 40\u20135967)","volume":"48","author":"I Bezprozvann","year":"1995","journal-title":"Mol Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1291\/hypres.19.31","article-title":"Disparate effects renal of calcium antagonists microcirculation","volume":"19","author":"K Hayashi","year":"1996","journal-title":"Hypertens Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.fjc.0000197539.12685.f5","article-title":"Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells","volume":"47","author":"K Imagawa","year":"2006","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:18:55Z","timestamp":1588994335000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109834"}},"subtitle":[],"editor":[{"given":"Ryuichi","family":"Morishita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109834","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]}}}